Association of Pathology Chairs - www.apcprods.org

 

 

Diamond Partners


ASCP

CAP

Gold Partners

Arup Laboratories

CAP
CAP
Kellison

Kellison

Mark Your Calendars!
Association of Pathology Chairs
2014 Annual Meeting

July 8-11, 2014
Seaport Boston Hotel
Boston, MA


Photo courtesy of Dom Miguel
Photography

Regional Meetings
Future APC Summer Meetings
Past APC Summer Meetings

 

Continuing Medical Education (CME) Information

CME Accreditation Statement: This activity ("APC 2013 Annual Meeting") is being planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society for Clinical Pathology (ASCP) and the Association of Pathology Chairs (APC). ASCP is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this "live" educational activity ("APC 2013 Annual Meeting") for a maximum of 25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Receiving CME Credit for this meeting is a two part process:  1) payment of the application fee; and 2) submission of a meeting evaluation. A CME certificate will not be issued unless both parts are completed.  If you are unsure if you submitted both the payment and the evaluation, please contact the APC Office at 301-634-7408. To receive credit, CME application fees and meeting evaluations are due by September 15, 2013.

Disclosure of Financial Relationships and Resolution of Conflicts of Interest:  In order to ensure balance, independence, objectivity and scientific rigor in all its educational activities, and in accordance with ACCME Standards, the ASCP requires all individuals in a position to influence and/or control the content of ASCP CME activities to disclose to the ASCP and subsequently to learners whether they do or do not have any relevant financial relationships with proprietary entities producing health care goods or services that are discussed in CME activities. Faculty are asked to use generic names in any discussion of therapeutic options, to base patient care recommendations on scientific evidence, and to base information regarding commercial products/services on scientific methods generally accepted by the medical community. All ASCP CME activities are evaluated by participants for the presence of any commercial bias and this input is used for subsequent CME planning decisions. The primary purpose of this activity is educational and the comments, opinions and/or recommendations expressed by the faculty or authors are their own and not those of ASCP or APC.

None of the planning committee members for this educational activity disclosed a relevant financial relationship. Presenters that indicate relevant financial relationships will be reviewed and conflicts of interest resolved.  The following presenters have indicated relationships that have been reviewed and commercial conflicts of interest resolved.  In all cases, it was determined that the financial relationship did not relate to the educational assignment or that the commercial entity does not produce, market, re-sell or distribute health care goods or services consumed by, or used on patients. If a presenter is not listed, then he/she had no commercial interest to disclose.

 

Invited Speaker Disclosures:

 

J. Charles Jennette, MD, University of North Carolina at Chapel Hill School of Medicine

Commercial Interest:  Genentech                        Role:  Consultant/Speaker        Compensation:  Consulting Fees

Commercial Interest:  GlaxoSmithKline               Role:  Consultant                    Compensation:  Consulting Fees

Commercial Interest:  Amicus Therapeutics         Role:  Consultant                    Compensation:  Consulting Fees

 

Michael Prystowsky, MD, PhD, Albert Einstein College of Medicine of Yeshiva University

Commercial Interest:  G2 Intelligence                 Role:  Speaker                        Compensation:  Honorarium

 

Thomas Wheeler, MD, Baylor College of Medicine

Commercial Interest:  DigiPath                           Role:  Advisory Board              Compensation:  Stock Options

 

 

Questions?  info@apcprods.org or 301-634-7880